(0.05%) 5 471.89 points
(0.09%) 39 147 points
(0.34%) 17 777 points
(-0.10%) $80.75
(-3.66%) $2.66
(-0.75%) $2 313.30
(0.28%) $28.95
(3.59%) $1 021.80
(0.27%) $0.936
(0.69%) $10.68
(0.46%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States...
Stats | |
---|---|
今日成交量 | 97 846 |
平均成交量 | 609 125 |
市值 | 47.37M |
EPS | $-0.300 ( Q1 | 2024-05-09 ) |
下一个收益日期 | ( $-0.320 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.470 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00300 (0.46%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-20 | Wallace Courtney | Buy | 50 000 | Stock Option (right to buy) |
2024-06-20 | Garner Elizabeth | Buy | 50 000 | Stock Option (right to buy) |
2024-06-20 | Cooper Graham K | Buy | 50 000 | Stock Option (right to buy) |
2024-06-20 | Klearman Micki | Buy | 50 000 | Stock Option (right to buy) |
2024-06-20 | Kauffman Michael | Buy | 50 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
-10.04 |
Last 100 transactions |
Buy: 7 765 931 | Sell: 10 044 723 |
音量 相关性
Kezar Life Sciences Inc 相关性
10 最正相关 |
---|
10 最负相关 | |
---|---|
RILYM | -0.809 |
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Kezar Life Sciences Inc 相关性 - 货币/商品
Kezar Life Sciences Inc 财务报表
Annual | 2023 |
营收: | $7.00M |
毛利润: | $5.93M (84.77 %) |
EPS: | $-1.400 |
FY | 2023 |
营收: | $7.00M |
毛利润: | $5.93M (84.77 %) |
EPS: | $-1.400 |
FY | 2022 |
营收: | $0 |
毛利润: | $-1.02M (0.00 %) |
EPS: | $-0.970 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-0.00102 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Kezar Life Sciences Inc
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of KZR-261; and KZR-TBD for the treatment of oncology and immunology. The company was incorporated in 2015 and is based in South San Francisco, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。